159 related articles for article (PubMed ID: 16086825)
1. High prostate cancer mortality in Norway: influence of Cancer Registry information?
Hernes E; Harvei S; Glattre E; Gjertsen F; Fosså SD
APMIS; 2005; 113(7-8):542-9. PubMed ID: 16086825
[TBL] [Abstract][Full Text] [Related]
2. High prostate cancer mortality in Norway evaluated by automated classification of medical entities.
Hernes E; Johansson LA; Fosså SD; Pedersen AG; Glattre E
Eur J Cancer Prev; 2008 Aug; 17(4):331-5. PubMed ID: 18562957
[TBL] [Abstract][Full Text] [Related]
3. Reliability of death certificates in prostate cancer patients.
Fall K; Strömberg F; Rosell J; Andrèn O; Varenhorst E;
Scand J Urol Nephrol; 2008; 42(4):352-7. PubMed ID: 18609293
[TBL] [Abstract][Full Text] [Related]
4. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995.
Albertsen PC; Walters S; Hanley JA
J Urol; 2000 Feb; 163(2):519-23. PubMed ID: 10647669
[TBL] [Abstract][Full Text] [Related]
5. High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm.
Godtman R; Holmberg E; Stranne J; Hugosson J
Scand J Urol Nephrol; 2011 Sep; 45(4):226-32. PubMed ID: 21463227
[TBL] [Abstract][Full Text] [Related]
6. Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics.
Copeland GE; Kirby RS
Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):792-7. PubMed ID: 17990340
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer surgery: the first 60 days. A population-based study.
Rostad H; Strand TE; Naalsund A; Talleraas O; Norstein J
Eur J Cardiothorac Surg; 2006 May; 29(5):824-8. PubMed ID: 16520052
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer and the Will Rogers phenomenon.
Albertsen PC; Hanley JA; Barrows GH; Penson DF; Kowalczyk PD; Sanders MM; Fine J
J Natl Cancer Inst; 2005 Sep; 97(17):1248-53. PubMed ID: 16145045
[TBL] [Abstract][Full Text] [Related]
10. High Norwegian prostate cancer mortality: evidence of over-reporting.
Löffeler S; Halland A; Weedon-Fekjær H; Nikitenko A; Ellingsen CL; Haug ES
Scand J Urol; 2018 Apr; 52(2):122-128. PubMed ID: 29325479
[TBL] [Abstract][Full Text] [Related]
11. Mortality trends for benign prostatic hyperplasia and prostate cancer in English populations 1979-2006.
Duncan ME; Goldacre MJ
BJU Int; 2011 Jan; 107(1):40-5. PubMed ID: 20590542
[TBL] [Abstract][Full Text] [Related]
12. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
[TBL] [Abstract][Full Text] [Related]
13. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study.
Houterman S; Janssen-Heijnen ML; Verheij CD; Kil PJ; van den Berg HA; Coebergh JW
Prostate Cancer Prostatic Dis; 2006; 9(2):179-84. PubMed ID: 16534509
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal gompertzian analysis of mortality from prostate cancer in Japan, 1955-1996.
Imaizumi Y
Cancer Detect Prev; 2000; 24(5):473-84. PubMed ID: 11129990
[TBL] [Abstract][Full Text] [Related]
15. [Incidence and mortality of prostate cancer in France: trends between 1978 and 2000].
Bauvin E; Remontet L; Grosclaude P; ;
Prog Urol; 2003 Dec; 13(6):1334-9. PubMed ID: 15000309
[TBL] [Abstract][Full Text] [Related]
16. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
17. The value of autopsies for determining the cause of death.
Alfsen GC; Mæhlen J
Tidsskr Nor Laegeforen; 2012 Jan; 132(2):147-51. PubMed ID: 22278269
[TBL] [Abstract][Full Text] [Related]
18. Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.
Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Dorey FJ; Walsh PC; Partin AW
J Clin Oncol; 2007 May; 25(13):1765-71. PubMed ID: 17470867
[TBL] [Abstract][Full Text] [Related]
19. Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice.
Litwin MS; Greenfield S; Elkin EP; Lubeck DP; Broering JM; Kaplan SH
Cancer; 2007 May; 109(9):1777-83. PubMed ID: 17354226
[TBL] [Abstract][Full Text] [Related]
20. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
Tonita JM; Skarsgard D; Muhajarine N
Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
